|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
FY2011
12 months to Dec 31, 2011
|
|
|---|---|---|---|---|
| Cash Flow from operating activities | ||||
| Net Income (Loss) | ||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||
| Depreciation and amortization | ||||
| Securities premium amortization and discount accretion, net | ||||
| (Gain) loss on sale of securities | ||||
| Earnings on bank-owned life insurance | ||||
| Mortgage banking services | ||||
| Originations of loans held for sale | ||||
| Proceeds from sales of loans held for sale | ||||
| Accretion on acquired loans | ||||
| Excess tax benefits from stock-based awards | ||||
| Deferred income tax expense (benefit) | ||||
| Writedowns and losses (gains) on sales of real estate acquired in settlement of loans, net | ||||
| Provision for credit losses | ||||
| Stock-based compensation | ||||
| (Increase) decrease in income taxes receivable | ||||
| (Increase) decrease in interest earned but not received | ||||
| Increase (decrease) in interest accrued but not paid | ||||
| Net (increase) decrease in other assets | ||||
| Net increase (decrease) in other liabilities | ||||
| Net cash provided by (used in) operating activities | ||||
| Cash Flow from investing activities | ||||
| Cash received from acquisition | ||||
| Purchase of bank-owned life insurance | ||||
| Proceeds from maturities of investment certificates of deposit | ||||
| Purchases of available for sale (“AFS”) securities | ||||
| Purchases of held to maturity (“HTM”) securities | ||||
| Proceeds from sales of AFS securities | ||||
| Proceeds from maturities, prepayments and calls of securities | ||||
| Proceeds from maturities, prepayments and calls of AFS securities | ||||
| Proceeds from maturities, prepayments and calls of HTM securities | ||||
| Net (increase) decrease in loans | ||||
| Proceeds from sales of loans | ||||
| Purchases of premises and equipment | ||||
| Proceeds from sales of premises and equipment | ||||
| Proceeds from sales of real estate acquired in settlement of loans | ||||
| Net cash provided by (used in) investing activities | ||||
| Cash Flow from financing activities | ||||
| Net increase (decrease) in demand deposits and NOW accounts | ||||
| Net increase (decrease) in savings and money market accounts | ||||
| Net increase (decrease) in time deposits | ||||
| Net increase (decrease) in borrowings from FHLB | ||||
| Net increase (decrease) in other borrowings | ||||
| Proceeds from issuance of preferred stock | ||||
| Dividends paid | ||||
| Common stock distributed | ||||
| Redemption of preferred stock and related expense | ||||
| Repurchase of stock warrant | ||||
| Exercise of stock options | ||||
| Cash paid in lieu of issuing shares pursuant to restricted stock units | ||||
| Excess tax benefits from stock-based awards | ||||
| Expense of stock issuance | ||||
| Net cash provided by (used in) financing activities | ||||
| Increase (decrease) in cash and cash equivalents | ||||
| Cash and cash equivalents at the beginning of the years | ||||
| Cash and cash equivalents at the end of the years | ||||
| Cash paid during the years for: | ||||
| Interest | ||||
| Income taxes | ||||
| Supplemental disclosures of noncash transactions | ||||
| Transfer of loans to loans held for sale | ||||
| Reclassification of investment securities from held to maturity to available for sale | ||||
| Transfer of loans to real estate acquired in settlement of loans | ||||
| Unrealized gains/(losses) on securities available for sale: | ||||
| Change in securities available for sale | ||||
| Change in deferred income taxes | ||||
| Change in shareholders’ equity | ||||
| Unrealized gain (loss) on cash flow hedges: | ||||
| Change in fair value of cash flow hedges | ||||
| Change in deferred income taxes | ||||
| Change in shareholders’ equity | ||||
| Conversion of preferred stock | ||||
| Acquisition: | ||||
| Fair value of assets acquired | ||||
| Fair value of liabilities assumed | ||||
Loading...
